Reye's syndrome is the most common metabolic encephalopathy of childhood, occurring with a prevalence of 0.8 to 5.5 cases per 100 000 in children 17 years of age and younger. Clinically, the disorder is characterized by persistent vomiting and progressive deterioration in the level of consciousness without focal neurological signs. Seizures are not a usual feature, though these may occur secondary to hypoglycemia, which may complicate Reye's syndrome in infants. However, the most malignant component of the disease is cerebral edema and elevation of intracranial pressure (ICP). The diagnosis of Reye's syndrome is established by documenting abnormal results of liver function tests, particularly elevation of blood ammonia and aspartate aminotransferase levels and a lengthened prothrombin time.
Although cases were probably observed earlier, it was described simultaneously in 1963 by Douglas Reye, an Australian pathologist, and George Johnson, an American pediatrician. Reye described the pathologic features in 21 cases observed over
Shaywitz BA, Lister G, Duncan CC. What Is the Best Treatment for Reye's Syndrome? Arch Neurol. 1986;43(7):730–731. doi:https://doi.org/10.1001/archneur.1986.00520070084024
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: